Addison Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Addison Capital's PFE Position: Q1 2026 in Review
Addison Capital increased its Pfizer (PFE) stake by 3% in Q1 2026, buying an estimated $20K and bringing the position to 25,949 shares worth $729K. The position accounts for 0.13% of the portfolio, ranked #122.
Addison Capital first reported a position in PFE in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.34M in Q1 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Addison Capital held 25,949 shares of Pfizer worth $729K as of Q1 2026.
- Addison Capital bought 753 Pfizer shares in Q1 2026, an estimated $20K.
- Pfizer made up 0.13% of Addison Capital's portfolio in Q1 2026, its #122 holding.
- Addison Capital first reported a position in Pfizer in Q4 2013 and has held it in 13 quarters since.
- Addison Capital's Pfizer position peaked at $1.34M in Q1 2015.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Addison Capital's 13F filing for Q1 2026, filed 29 Apr 2026.